Omani Samani Reza, Almasi Hashiani Amir, Razavi Maryam, Vesali Samira, Rezaeinejad Mahroo, Maroufizadeh Saman, Sepidarkish Mahdi
Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Pregnancy Health Research Center, Department of Obstetrics and Gynecology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Int J Reprod Biomed. 2018 Nov;16(11):665-678.
Understanding the prevalence of menstrual disorders has important implications for both health service planning and risk factor epidemiology.
The aim of this review is to identify and collate studies describing the prevalence of menstrual disorders in Iran.
Studies with original data related to the prevalence of menstrual disorders were identified via searching six electronic databases and reviewing citations. All abstracts or titles found by the electronic searches were independently scrutinized by two reviewers. The Meta-analysis was performed with a random effects model, considering the remarkable heterogeneity among studies. A total of 35 eligible epidemiological studies were included in this review.
Overall, the pooled prevalence of primary dysmenorrhea was 73.27% (95% CI=65.12-81.42). The mean proportion of women with oligomenorrhea was 13.11% (95.5%, 95% CI: 10.04-16.19). We identified 16 studies that reported polymenorrhoea with a random effect of pooled prevalence estimate of 9.94% (95% CI 7.33%-12.56%). The prevalence estimate of hypermenorrhea was 12.94% (95% CI 9.31%-16.57%). Overall prevalence of hypomenorrhea was 5.25% (95% CI 3.20%-7.30%), ranging from 0.9- 12.90%. Pooling six studies that reported estimates for menorrhagia, the overall prevalence was 19.24% (95% CI 12.78-25.69). Overall, 6.04% (95% CI: 1.99-10.08) of the women were shown to have metrorrhagia.
This systematic review suggests that the average prevalence of menstrual disorders in Iran is substantial. It has been neglected as a fundamental problem of women's reproductive health. Diagnosis and treatment of these disorders should be included in the primary health care system of reproductive health.
了解月经紊乱的患病率对卫生服务规划和风险因素流行病学均具有重要意义。
本综述旨在识别并整理描述伊朗月经紊乱患病率的研究。
通过检索六个电子数据库并查阅参考文献,找出与月经紊乱患病率相关的原始数据研究。两名评审员独立审查电子检索找到的所有摘要或标题。考虑到各研究之间存在显著异质性,采用随机效应模型进行Meta分析。本综述共纳入35项符合条件的流行病学研究。
总体而言,原发性痛经的合并患病率为73.27%(95%置信区间=65.12 - 81.42)。月经过少女性的平均比例为13.11%(95.5%,95%置信区间:10.04 - 16.19)。我们确定了16项报告了月经过多的研究,其合并患病率估计的随机效应为9.94%(95%置信区间7.33% - 12.56%)。月经过多的患病率估计为12.94%(95%置信区间9.31% - 16.57%)。月经过少的总体患病率为5.25%(95%置信区间3.20% - 7.30%),范围为0.9 - 12.90%。汇总六项报告了月经过多估计值的研究,总体患病率为19.24%(95%置信区间12.78 - 25.69)。总体而言,6.04%(95%置信区间:1.99 - 10.08)的女性被证明有子宫出血。
本系统综述表明,伊朗月经紊乱的平均患病率较高。它作为女性生殖健康的一个基本问题一直被忽视。这些疾病的诊断和治疗应纳入生殖健康初级卫生保健系统。